News und Analysen
![RACHAT ACTIONS - CONTRAT DE LIQUIDITES - OCTOBRE 2011](/assets/news/news6-ad07925a95156ae03dbe17caf44a9dc29f254ff2c2a42c7678d35288ad55cec8.png)
RACHAT ACTIONS - CONTRAT DE LIQUIDITES - OCTOBRE 2011
PROGRAMME DE RACHAT DE TITRES
Dénomination sociale de l’émetteur :
MEDICREA
Numéro de visa du programme :
![Communiqué de mise à disposition des documents préparatoires de lAssemblée générale](/assets/news/news9-b4ba75b613b80e3d047ded18f34335e7f81348578b67aee3f1469440916c031e.png)
Communiqué de mise à disposition des documents préparatoires de lAssemblée générale
Société anonyme au capital de 3.303.261 euros
Siège social :
12, avenue de la Dame - Zone euro 2000
30132 CAISSARGUES
305 635 039 RCS NÎMES
![DGAP-News: Abivax Finanzkalender 2021](/assets/news/news4-fce0efe65d8ba787508ef718c0a20bed51e468dbc656c188c43e13f15b4a4f53.png)
DGAP-News: Abivax Finanzkalender 2021
DGAP-News: Abivax Finanzkalender 2021
![DGAP-News: Abivax 2021 Financial Communication Calendar](/assets/news/news5-af8c677c86bb4b693f58afef33877e6f798ff0d7e2b4fa69b6e89960549b5ee6.png)
DGAP-News: Abivax 2021 Financial Communication Calendar
DGAP-News: Abivax 2021 Financial Communication Calendar
![Sartorius Stedim Biotech SA: DECLARATION RELATIVE TO THE NUMBER OF SHARES AND VOTING RIGHTS MAKING UP THE ISSUED CAPITAL](/assets/news/news12-a6c8e663da6f66e4f8b76885d84b91bc276bfd92fd8727e9ade1f1d9f4df9b67.png)
Sartorius Stedim Biotech SA: DECLARATION RELATIVE TO THE NUMBER OF SHARES AND VOTING RIGHTS MAKING UP THE ISSUED CAPITAL
Sartorius Stedim Biotech SA: DECLARATION RELATIVE TO THE NUMBER OF SHARES AND VOTING RIGHTS MAKING UP THE ISSUED CAPITAL
![DGAP-News: Abivax schließt Patientenrekrutierung für seine klinische Phase-2b-Induktionsstudie mit ABX464 zur Behandlung von Colitis Ulcerosa ab](/assets/news/news12-a6c8e663da6f66e4f8b76885d84b91bc276bfd92fd8727e9ade1f1d9f4df9b67.png)
DGAP-News: Abivax schließt Patientenrekrutierung für seine klinische Phase-2b-Induktionsstudie mit ABX464 zur Behandlung von Colitis Ulcerosa ab
DGAP-News: Abivax schließt Patientenrekrutierung für seine klinische Phase-2b-Induktionsstudie mit ABX464 zur Behandlung von Colitis Ulcerosa ab
![DGAP-News: Abivax completes recruitment of ABX464 Phase 2b induction study in ulcerative colitis](/assets/news/news13-125fa69a38b6955d740c18f7e750c42a3317f6873eded3044187d2ece3aa0ac7.png)
DGAP-News: Abivax completes recruitment of ABX464 Phase 2b induction study in ulcerative colitis
DGAP-News: Abivax completes recruitment of ABX464 Phase 2b induction study in ulcerative colitis
![DGAP-News: Abivax Receives 'Best Technology Award' at the European Mediscience Awards 2020](/assets/news/news14-e52b56a6adda780de8ab40d75cabe14dcfa77fc9676e986401297a29e68c991e.png)
DGAP-News: Abivax Receives 'Best Technology Award' at the European Mediscience Awards 2020
DGAP-News: Abivax Receives 'Best Technology Award' at the European Mediscience Awards 2020
![DGAP-News: Abivax bei den European Mediscience Awards 2020 mit dem 'Best Technology Award' ausgezeichnet](/assets/news/news13-125fa69a38b6955d740c18f7e750c42a3317f6873eded3044187d2ece3aa0ac7.png)
DGAP-News: Abivax bei den European Mediscience Awards 2020 mit dem 'Best Technology Award' ausgezeichnet
DGAP-News: Abivax bei den European Mediscience Awards 2020 mit dem 'Best Technology Award' ausgezeichnet
![Pharnext 2019 Universal Registration Document Approved by AMF](/assets/news/news8-29d1d55c755b03e328399113b5bdd004223f995e95194ba5ee80af9da39a41e3.png)
Pharnext 2019 Universal Registration Document Approved by AMF
Pharnext 2019 Universal Registration Document Approved by AMF
![Sartorius Stedim Biotech SA: Notification of transactions made by persons discharging managerial responsibilities and persons closely related to them](/assets/news/news1-f26f2455ece0c3cbea64441818e795358cadddddb27e796f883ae2bd06f66139.png)
Sartorius Stedim Biotech SA: Notification of transactions made by persons discharging managerial responsibilities and persons closely related to them
Sartorius Stedim Biotech SA: Notification of transactions made by persons discharging managerial responsibilities and persons closely related to them
![Sartorius Stedim Biotech SA: DECLARATION RELATIVE TO THE NUMBER OF SHARES AND VOTING RIGHTS MAKING UP THE ISSUED CAPITALDECLARATION RELATIVE TO THE NUMBER OF SHARES AND VOTING RIGHTS MAKING UP THE ISSUED CAPITAL](/assets/news/news16-82a218458f0e15ae617f9186b258dfd3add112716106c6ee3cbb48563ccdef52.png)
Sartorius Stedim Biotech SA: DECLARATION RELATIVE TO THE NUMBER OF SHARES AND VOTING RIGHTS MAKING UP THE ISSUED CAPITALDECLARATION RELATIVE TO THE NUMBER OF SHARES AND VOTING RIGHTS MAKING UP THE ISSUED CAPITAL
Sartorius Stedim Biotech SA: DECLARATION RELATIVE TO THE NUMBER OF SHARES AND VOTING RIGHTS MAKING UP THE ISSUED CAPITALDECLARATION RELATIVE TO THE NUMBER OF SHARES AND VOTING RIGHTS MAKING UP THE ISSUED CAPITAL
![DGAP-News: Abivax announces webcast and teleconference following recent oversubscribed capital increase of EUR 28m at market price](/assets/news/news10-be520e400538f920c1970757e43cd0aa35625c1095be243829bb7a152346bd95.png)
DGAP-News: Abivax announces webcast and teleconference following recent oversubscribed capital increase of EUR 28m at market price
DGAP-News: Abivax announces webcast and teleconference following recent oversubscribed capital increase of EUR 28m at market price
![DGAP-News: Abivax kündigt Webcast und Telefonkonferenz zur kürzlich zum Aktuellen Börsenkurs abgeschlossenen, überzeichneten Kapitalerhöhung über EUR 28 Mio. an](/assets/news/news5-af8c677c86bb4b693f58afef33877e6f798ff0d7e2b4fa69b6e89960549b5ee6.png)
DGAP-News: Abivax kündigt Webcast und Telefonkonferenz zur kürzlich zum Aktuellen Börsenkurs abgeschlossenen, überzeichneten Kapitalerhöhung über EUR 28 Mio. an
DGAP-News: Abivax kündigt Webcast und Telefonkonferenz zur kürzlich zum Aktuellen Börsenkurs abgeschlossenen, überzeichneten Kapitalerhöhung über EUR 28 Mio. an
![Pharnext: Shareholder Letter](/assets/news/news6-ad07925a95156ae03dbe17caf44a9dc29f254ff2c2a42c7678d35288ad55cec8.png)
Pharnext: Shareholder Letter
Pharnext: Shareholder Letter
![DGAP-News: Abivax gibt erfolgreichen Abschluss seiner überzeichneten Kapitalerhöhung in Höhe von EUR 28 Mio. bekannt](/assets/news/news15-207f60e93f55a63563671c62b1e07d0bc426e50a03c286a608f29c8138f4f1de.png)
DGAP-News: Abivax gibt erfolgreichen Abschluss seiner überzeichneten Kapitalerhöhung in Höhe von EUR 28 Mio. bekannt
DGAP-News: Abivax gibt erfolgreichen Abschluss seiner überzeichneten Kapitalerhöhung in Höhe von EUR 28 Mio. bekannt
![DGAP-News: Abivax announces the success of its oversubscribed capital increase of EUR 28m at market price](/assets/news/news7-ff65ae96e2a4b99929975e34f30f51b3393455f312fc86852d9fc8020c5054eb.png)
DGAP-News: Abivax announces the success of its oversubscribed capital increase of EUR 28m at market price
DGAP-News: Abivax announces the success of its oversubscribed capital increase of EUR 28m at market price
![Pharnext announces 2020 half-year results](/assets/news/news2-a19c21d90ec8043c932052617f43da76ea8e48ecd096318e237ea24d69a5c8b8.png)
Pharnext announces 2020 half-year results
Pharnext announces 2020 half-year results
![Pharnext to Host Research and Development Event Today](/assets/news/news10-be520e400538f920c1970757e43cd0aa35625c1095be243829bb7a152346bd95.png)
Pharnext to Host Research and Development Event Today
Pharnext to Host Research and Development Event Today
![DGAP-News: Abivax sichert sich nicht-verwässernde Finanzierung über EUR 15 Millionen von Kreos Capital](/assets/news/news19-14feaf1b3ac689101974b5354f2ab8bb5cb2e7cb49a06b120b8491e9ebba31f4.png)
DGAP-News: Abivax sichert sich nicht-verwässernde Finanzierung über EUR 15 Millionen von Kreos Capital
DGAP-News: Abivax sichert sich nicht-verwässernde Finanzierung über EUR 15 Millionen von Kreos Capital
![DGAP-News: Abivax secures EUR 15m non-dilutive financing from Kreos Capital](/assets/news/news1-f26f2455ece0c3cbea64441818e795358cadddddb27e796f883ae2bd06f66139.png)
DGAP-News: Abivax secures EUR 15m non-dilutive financing from Kreos Capital
DGAP-News: Abivax secures EUR 15m non-dilutive financing from Kreos Capital
![Sartorius Stedim Biotech SA: DECLARATION RELATIVE TO THE NUMBER OF SHARES AND VOTING RIGHTS MAKING UP THE ISSUED CAPITAL](/assets/news/news12-a6c8e663da6f66e4f8b76885d84b91bc276bfd92fd8727e9ade1f1d9f4df9b67.png)
Sartorius Stedim Biotech SA: DECLARATION RELATIVE TO THE NUMBER OF SHARES AND VOTING RIGHTS MAKING UP THE ISSUED CAPITAL
Sartorius Stedim Biotech SA: DECLARATION RELATIVE TO THE NUMBER OF SHARES AND VOTING RIGHTS MAKING UP THE ISSUED CAPITAL
![DGAP-News: Abivax announces the release of its 2020 half-year financial report](/assets/news/news1-f26f2455ece0c3cbea64441818e795358cadddddb27e796f883ae2bd06f66139.png)
DGAP-News: Abivax announces the release of its 2020 half-year financial report
DGAP-News: Abivax announces the release of its 2020 half-year financial report
![DGAP-News: Abivax veröffentlicht Halbjahresfinanzbericht 2020](/assets/news/news18-f135f6c168ef56d2b112890081403b0a310104acfadbf4a8f72634bd390e98ac.png)
DGAP-News: Abivax veröffentlicht Halbjahresfinanzbericht 2020
DGAP-News: Abivax veröffentlicht Halbjahresfinanzbericht 2020
![Edison Investment Research Limited: Edison issues initiation on Pharnext (ALPHA)](/assets/news/news12-a6c8e663da6f66e4f8b76885d84b91bc276bfd92fd8727e9ade1f1d9f4df9b67.png)
Edison Investment Research Limited: Edison issues initiation on Pharnext (ALPHA)
Edison Investment Research Limited: Edison issues initiation on Pharnext (ALPHA)